EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Protecting Newborns from Multidrug-Resistant Infections: The Emerging Role of Bacteriophages

Olaf Bajrak, Andrzej Górski iD, Ewa Jończyk-Matysiak iD

Viruses · 12.06.2026 · 18 (6) · 664

DOI: 10.3390/v18060664 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 12.06.2026. Verfasst von Olaf Bajrak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Bacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (HIIET PAS), 53-114 Wrocław, Poland. Hauptthemen laut MEDLINE: Bacteriophages, Phage Therapy, Bacterial Infections, Drug Resistance, Multiple, Bacterial. Die Arbeit nennt 420 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ludwik Hirszfeld Institute of Immunology and Experimental Therapy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Newborns may suffer from dangerous bacterial infections caused by life-threatening multi-drug resistant pathogens. Thus, despite bactericidal capabilities of antibiotics, microorganisms are known to circumvent this therapy, and a new, more effective type of remedy is needed. An increasingly recognized strategy for addressing these challenges is the use of bacteriophages—viruses infecting bacteria—collectively referred to as phage therapy. Nonetheless, the research considering phage therapy amongst newborns is still at a pioneering stage, owing to the scarcity of systematic investigations and the prevalence of case-study data, leaving room for further discovery and analysis. This review summarizes the information needed to understand this complex issue, considering the description of pathogens causing infections affecting newborns, the formation of the early microbiota and phageome (defining its composition followed by an influence on immune system development), and the possible use of bacteriophages in the treatment, which may be complicated by ethical concerns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteriophagesPhage TherapyBacterial InfectionsDrug Resistance, Multiple, BacterialHumansInfant, NewbornBacteriaMicrobiotaAnti-Bacterial Agents

Stichwörter der Autor:innen

ESKAPE groupinfant microbiotanewborn infectionsphage therapy

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Bacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (HIIET PAS), 53-114 Wrocław, Poland.
  • Phage Therapy Unit, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (HIIET PAS), 53-114 Wrocław, Poland.
  • Department of Clinical Immunology, Medical University of Warsaw, 02-006 Warsaw, Poland.

ORCID-Profile: Andrzej Górski, Ewa Jończyk-Matysiak

Förderung

  • Ludwik Hirszfeld Institute of Immunology and Experimental Therapy

Zitieren

APA

Bajrak, O., Górski, A., & Jończyk-Matysiak, E. (2026). Protecting Newborns from Multidrug-Resistant Infections: The Emerging Role of Bacteriophages. Viruses, 18(6), 664. https://doi.org/10.3390/v18060664

Vancouver

Bajrak O, Górski A, Jończyk-Matysiak E. Protecting Newborns from Multidrug-Resistant Infections: The Emerging Role of Bacteriophages. Viruses. 2026;18(6):664. doi:10.3390/v18060664

BibTeX
@article{Bajrak2026,
  author = {Bajrak, Olaf and Górski, Andrzej and Jończyk-Matysiak, Ewa},
  title = {Protecting Newborns from Multidrug-Resistant Infections: The Emerging Role of Bacteriophages},
  journal = {Viruses},
  year = {2026},
  volume = {18},
  number = {6},
  pages = {664},
  doi = {10.3390/v18060664}
}
Kostenlos starten →